Skip to main content

Month: September 2020

Correction: Zealand Pharma announces amendments to its Articles of Association following the granting of warrants

Company announcement – No. 50 / 2020Correction: Zealand Pharma announces amendments to its Articles of Association following the granting of warrantsCopenhagen, September 22, 2020 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that its Articles of Association have been amended to reflect the recent grant of warrants to employees, as announced in Company Announcement no. 49/2020 on September 14, 2020. Zealand issues this correction to reference the changes to the Articles of Association.The warrant program is an incentive scheme reflecting Zealand’s objective to attract and retain first-rate employees and help ensure shared short- and long-term interests for the management, employees...

Continue reading

Nexus REIT Announces September 2020 Distribution and Issuance of Units to Settle Debt

TORONTO and MONTREAL, Sept. 22, 2020 (GLOBE NEWSWIRE) — Nexus Real Estate Investment Trust (the “REIT”) (TSXV: NXR.UN) announced today the declaration of the September 2020 distribution.The REIT will make a cash distribution in the amount of $0.01333 per unit, representing $0.16 per unit on an annualized basis, payable October 15, 2020 to unitholders of record as of September 30, 2020.The REIT’s current distribution per unit continues to be $0.01333 per month. The REIT’s distribution reinvestment plan (“DRIP”) entitles eligible unitholders to elect to receive all, or a portion of the cash distributions of the REIT reinvested in units of the REIT. Eligible unitholders who so elect will receive a bonus distribution of units equal to 4% of each distribution that was reinvested by them under the DRIP.Insider participation in the DRIP...

Continue reading

FPI Nexus annonce la distribution du mois de septembre 2020 et une émission de parts en règlement d’une dette

MONTRÉAL et TORONTO , 22 sept. 2020 (GLOBE NEWSWIRE) — Le Fonds de Placement Immobilier Nexus (le « FPI Nexus » ou le « FPI ») (TSXV : NXR.UN) a annoncé aujourd’hui la déclaration de la distribution de septembre 2020.Le FPI versera une distribution en espèces de 0,01333 $ par part, représentant 0,16 $ par part sur une base annualisée, payable le 15 octobre 2020 aux détenteurs de parts inscrits au 30 septembre 2020.La distribution mensuelle courante du FPI demeure à 0,01333 $ par part. Le plan de réinvestissement de distribution (mieux connu sous l’acronyme anglais « DRIP ») du FPI permet aux détenteurs de parts éligibles de choisir de faire réinvestir la totalité ou une partie des distributions en espèces du FPI dans des parts supplémentaires du FPI. Les détenteurs de parts éligibles qui choisissent cette option recevront ainsi...

Continue reading

Protara Therapeutics Announces Pricing of $147.6 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock

NEW YORK, Sept. 22, 2020 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced the pricing of two concurrent but separate underwritten public offerings (together, the “Offerings”) of (i) 4,600,000 shares of its common stock and (ii) 4,148 shares of its non-voting Series 1 Convertible Preferred Stock (the “Series 1 preferred stock”). The public offering price of each share of common stock is $16.87 and the public offering price of each share of Series 1 preferred stock is $16,873.54. In addition, Protara has granted the underwriters a 30-day option to purchase additional shares of common stock of up to 15% of the aggregate number of shares offered in the common stock offering....

Continue reading

The L.S. Starrett Company Implements Strategic Measures to Strengthen Financial Profile

ATHOL, MA, Sept. 22, 2020 (GLOBE NEWSWIRE) — The L.S. Starrett Company (NYSE: SCX) (Starrett or the Company), a leading manufacturer of high-end precision tools, cutting equipment, and metrology systems for industrial, professional and consumer markets, today announced key strategic measures the Company has taken to strengthen its financial profile  as a result of the global COVID-19 pandemic.At the start of the global COVID-19 pandemic, Starrett immediately took measures to ensure the safety and well-being of its employees, the long-term financial health of the Company, while remaining in operation as an “essential business”. As a result of instituting extensive safety protocols throughout its global business, the Company mitigated risk and protected the health and safety of its valued employees, customers, distributors and communities....

Continue reading

Microchip Introduces No-Cost, License- and Royalty-Free Ensemble Graphics Toolkit to Speed Linux® Graphical User Interface Development

CHANDLER, Ariz., Sept. 22, 2020 (GLOBE NEWSWIRE) — Graphical user interfaces (GUIs) and interactive touchscreen displays provide intuitive user experiences in applications from robotic and machine controls to medical user interfaces, automotive instrumentation and home and building automation systems. A well-designed GUI enables users to process information more quickly and interact more effectively with a product. Microchip Technology Inc. (Nasdaq: MCHP) today announced a new GUI development toolkit for its portfolio of 32-bit microprocessors (MPUs) running Linux, helping designers of industrial, medical, consumer and automotive graphical displays to reduce development cost and time-to-market.Microchip’s new Ensemble Graphics Toolkit is a free and open-source C++ GUI suite for the company’s SAMA5 and SAM9 series of Arm® Cortex®-A5...

Continue reading

Galectin Therapeutics Announces Investor Conference Call and Webinar on September 29, 2020

NORCROSS, Ga., Sept. 22, 2020 (GLOBE NEWSWIRE) — Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, announced today that the Company will host an investor conference call and webinar to discuss the Company’s NASH-RX clinical trial and to introduce its new CEO, Joel Lewis. The Investor Call is scheduled for Tuesday, September 29, 2020, at 4:00 p.m. EDT.The presentation can be accessed by dialing (844) 899-6544 and entering the conference ID: 3695038 or at the following webcast link: https://edge.media-server.com/mmc/p/hmudntyg. A copy of the presentation to be used for the call can be found on the Company’s website at https://investor.galectintherapeutics.com/investor-relations.The call is expected to last one hour, including a Q&A session that will follow the formal...

Continue reading

Correction: Final terms for bond to be opened 23rd September 2020

To Nasdaq Copenhagen A/S                                                               21 st   September 2020                                                                                                             Announcement no. 95/2020Correction: The terms for value at Redemption due to negative interest rate was not set in the previously published final terms. The attached final terms replace previously published ones.The full prospectus for the Bond consist of the attached final terms and the previously disclosed ”Base Prospectus for the issue of Covered Bonds (SDO), Mortgage bonds (“RO”) and Mortgage Bonds (RO) and bonds issued pursuant to Section 15 of the Danish Mortgage-Credit Loans and Mortgage-Credit Bonds etc. Act (Section 15 Bonds).”, dated February 24th, 2020.Jyske Realkredit’s base prospectus is available on Jyske Realkredit’s...

Continue reading

Correction: Endelige vilkår for ny obligation der åbnes den 23. september 2020

Til Nasdaq Copenhagen A/S                                                                                       21. september 2020                                                                                                                                                 Meddelelse nr. 95/2020Rettelse: Vilkåret for kurs ved udtrækning som følge af negativ rente var ikke sat i de tidligere offentliggjorte endelige vilkår. Vedlagte endelige vilkår erstatter tidligere offentliggjorte. Jyske Realkredit åbner den 23. september 2020 ny særligt dækkede obligation (SDO). Med denne meddelelse følger de endelige vilkår for obligationerne.Det samlede prospekt for obligationerne består af vedlagte endelige vilkår og det tidligere offentliggjorte ”Basisprospekt for udstedelse af Særligt Dækkede Obligationer (SDO), Realkreditobligationer (RO) og...

Continue reading

ZDD listed on OTC market in USA

Boca Raton, FL, Sept. 22, 2020 (GLOBE NEWSWIRE) — The assets of Henan Anjia e-commerce Co., Ltd. (Stock Code: zdd) will be loaded into the listed company in the form of reverse merger and acquisition. The company will issue 1 billion shares, and Cui Weiming will be appointed as the chairman and director, and Chang Xu as the director. The company’s “earn more” brand has deeply cultivated the differentiated e-commerce and community e-commerce to seek the welfare of the common people. The company appointed Ouyang Chengguo as the chairman, Wen Qingrui as the vice chairman, Wang Jinhui as the CEO, Ouyang Chengguo, Wen Qingrui, Wang Jinhui, Ma Liying, LV Baoshu, Xu Yulan, Yin Li, Han fengzhe and Liu Huiwu as directors, and Ouyang Jianwen as the Secretary of the board of directors.Zdd acquired OMPs through reverse merger...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.